Technical Analysis for ARVN - Arvinas, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 31.57 | 0.41% | 0.13 |
ARVN closed up 0.41 percent on Monday, May 13, 2024, on 74 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Flat | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Resistance | Bearish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Fell Below 200 DMA | Bearish | 0.41% | |
| Bollinger Band Squeeze | Range Contraction | 0.41% | |
| NR7 | Range Contraction | 0.41% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 11 hours ago |
| 200 DMA Resistance | about 11 hours ago |
| Possible NR7 | about 12 hours ago |
| Possible Inside Day | about 12 hours ago |
| 10 DMA Resistance | about 16 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/03/2024
Arvinas Inc. is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses its proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC™ protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Disease Genetics Metabolism Chimera
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Disease Genetics Metabolism Chimera
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 53.08 |
| 52 Week Low | 13.57 |
| Average Volume | 681,963 |
| 200-Day Moving Average | 31.64 |
| 50-Day Moving Average | 38.21 |
| 20-Day Moving Average | 32.83 |
| 10-Day Moving Average | 32.34 |
| Average True Range | 1.67 |
| RSI (14) | 35.90 |
| ADX | 20.75 |
| +DI | 17.45 |
| -DI | 23.65 |
| Chandelier Exit (Long, 3 ATRs) | 33.55 |
| Chandelier Exit (Short, 3 ATRs) | 35.92 |
| Upper Bollinger Bands | 34.99 |
| Lower Bollinger Band | 30.67 |
| Percent B (%b) | 0.21 |
| BandWidth | 13.14 |
| MACD Line | -1.67 |
| MACD Signal Line | -1.91 |
| MACD Histogram | 0.2416 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 33.18 | ||||
| Resistance 3 (R3) | 33.28 | 32.84 | 32.91 | ||
| Resistance 2 (R2) | 32.84 | 32.44 | 32.79 | 32.82 | |
| Resistance 1 (R1) | 32.21 | 32.18 | 31.99 | 32.11 | 32.73 |
| Pivot Point | 31.77 | 31.77 | 31.67 | 31.72 | 31.77 |
| Support 1 (S1) | 31.14 | 31.36 | 30.92 | 31.03 | 30.41 |
| Support 2 (S2) | 30.70 | 31.11 | 30.65 | 30.32 | |
| Support 3 (S3) | 30.07 | 30.70 | 30.23 | ||
| Support 4 (S4) | 29.96 |
